All filters
Slidesets
Does HIV-Related Vascular Disease Gradually Improve with Accumulating Time on ART? Data from CHER- Dr. Steven Innes
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
New Therapeutic Approaches to ART in Pregnancy- Laurent Mandelbrot, MD
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
A Last Barrier to eMTCT: Acute HIV Infection in Pregnancy/Breastfeeding- Alison Drake, MPH, PhD
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Pregnancy and Neonatal Outcomes following Prenatal Exposure to Dolutegravir- Dr. Claire Thorne
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Intensification of antiretroviral treatment with raltegravir for late-presenting HIV-infected pregnant women- Dr. Thanyawee Puthanakit
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Is Tenofovir Use in Pregnancy Associated with Preterm Delivery? A Canadian Perinatal HIV Surveillance Program Analysis- Dr. Jason Brophy
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Asymptomatic Hematologic Toxicity Associated with Very Early Combination Antiretroviral Therapy (cART) in In Utero HIV-infected Infants- Dr. Ellen Chadwick
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Hepatotoxicity in HIV+ Postpartum Women Initiating Efavirenz-Containing Regimens- Dr. Patricia Flynn
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
The population effect of HIV exposure in HIV-uninfected children on infant mortality in Botswana and South Africa- Dr. Amy Slogrove
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Developmental outcomes of breastfed, HIV-exposed uninfected and breastfed, HIV-unexposed children in the context of universal maternal antiretroviral therapy: a prospective cohort-Dr. Stanzi Le Roux
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
HIV -Affected but Not Infected – The Dilemma of HIV-Exposed but Uninfected Infants- Kathleen Powis, MD, MPH, MBA
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
The Second Generation: Pregnancy in Perinatal HIV Infected Women- Jennifer Jao, MD, MPH
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Inequality in mortality and access to antiretroviral therapy in adolescents living with perinatally-acquired HIV in sub-Saharan Africa: a Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Cohort Collaboration-Dr. Marcel Yotebieng
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Attrition and treatment outcomes among perinatally and behaviourally HIV-infected adolescents and youths in Thai National AIDS program- Dr. Sirinya Teeraananchai
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Experiences of transition to adult care and readiness to self-manage care in young people with perinatal HIV in England- Dr. Ali Judd
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
What constitutes adolescent-friendly health services? Clinic characteristics that attenuate internalised HIV stigma among adolescents living with HIV- Dr. Marija Pantelic
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Debate: Self-testing should be implemented for all adolescents - Pro- Cheryl Johnson
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Discussion: What constitutes “Adolescent Friendly” Programming?- Nicola Willis, MPhil
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Discussion: What constitutes “Adolescent Friendly” Programming?- Claude Mellins, PhD
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Debate: Self-testing should be implemented for all adolescents - Con- Gabriel Chamie, MD
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Discussion: What constitutes “Adolescent Friendly” Programming?- Catherine Dollfus, MD, MPH
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
WHO Target 90-90-90 : Achievable for Latin America- Alejandro Afani, MD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Slidesets
HIV in Latin America: 35 years later- Marcelo Wolff, MD, FACP, FIDSA
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Slidesets
Difficult to reach populations in Latin America- Ana Paulina Celi de la Torre, MD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017